1987
DOI: 10.1159/000242623
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Metoclopramide Therapy on Arginine Vasopressin Excretion and Renal Water Handling in Premature Infants

Abstract: The role of endogenous dopamine (DA) in regulating arginine vasopressin (AVP) release and renal water excretion was studied in 10 premature infants with a mean birth weight of 1,341 g (range 1,150–1,660 g) and a mean gestational age of 30.2 weeks (28–33 weeks), who were given metoclopramide (MTC), a specific DA antagonist. It was demonstrated that in response to MTC urine flow rate increased significantly from a basal value of 0.90 ± 0.07 to 1.27 ± 0.09 ml/min/1.73 m2 (mean ± SE; p < 0.01), urinary … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1988
1988
2000
2000

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…After metoclopramide ad ministration there was a significant fall in urinary AVP excretion indicating that, con trary to adults, in low birth weight prema ture infants endogenous dopamine enhances rather than inhibits pituitary AVP secretion. Increased dopaminergic activity in sodiumdepleted, hyponatrémie premature infants may contribute, therefore, to restore the vol ume of body fluid compartments through stimulating AVP release [33].…”
Section: Observations In Human Neonatesmentioning
confidence: 99%
“…After metoclopramide ad ministration there was a significant fall in urinary AVP excretion indicating that, con trary to adults, in low birth weight prema ture infants endogenous dopamine enhances rather than inhibits pituitary AVP secretion. Increased dopaminergic activity in sodiumdepleted, hyponatrémie premature infants may contribute, therefore, to restore the vol ume of body fluid compartments through stimulating AVP release [33].…”
Section: Observations In Human Neonatesmentioning
confidence: 99%
“…D 1 dopamine receptor; sodium-hydrogen exchanger 3; G␤/␥ subunit; renal proximal tubules; ontogeny THE DECREASED NATRIURETIC effect of dopamine and dopamine agonists in the young of many species, including humans, is well documented (24,26,32,34,35). The decreased natriuretic effect of dopamine is caused by impaired inhibition of sodium reabsorption via D 1 -like receptors and activation of sodium reabsorption via ␣-adrenergic and D 2 -like receptors (13,15,26,32,35,36). The impaired action of D 1 -like receptors in the young is caused by both decreased renal vasodilatory and tubular effects (13).…”
mentioning
confidence: 99%